This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Eli Lilly is slashing its clinical trial activities in response to the COVID-19...
CureVac ramps up COVID-19 mRNA vaccine effort as Moderna analysts raise questions...
Credit: Christopher J. Malyniuk Chemotherapeutic drugs, also known as antineoplastic...
The death rate from confirmed COVID-19 cases is estimated at 1.38%, while the overall...
CRISPR has been all over the news in the past couple of years, and with reason....
A large study found Nanoflu to be non-inferior to Sanofi's Fluzone. Safety results,...